by
Thomas Dworetzky, Contributing Reporter | July 09, 2018
The VersaVision features a proprietary detector that permits five times more geometric magnification than other systems on the market.
In May, the company got
FDA clearance for its VisionCT, “the first and only FDA-approved clinical CT system dedicated to delivering true 3D specimen radiography,” according to a company statement.
Ad Statistics
Times Displayed: 109902
Times Visited: 6641 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
VisionCT is designed to provide easily navigable, true 3D data and rendering of the specimen, in addition to immediate traditional orthogonal images.
It was designed to improve detailed margin assessment by automatically taking images around the entire specimen and then reconstructing a navigable 3D rendering in real time. The system is able to reconstruct the specimen in as many as 1024 slices at a standard thickness of 100 microns, according to the company.
“As imaging innovations in breast screening continue to drive earlier detection of abnormalities in breast tissue, there is a parallel need for ongoing improvements in methods for assessing and confirming specimen margin status during surgery,” said O’Driscoll. “VisionCT gives providers a clearer, more detailed view of breast specimen margin status than ever before.”
Back to HCB News
